An overview of carbapenem-resistant Klebsiella pneumoniae: Epidemiology and control measures

Reviews and Research in Medical Microbiology

Volumn 25, Issue 1, 2014, Pages 7-14

  Spagnolo, Anna Maria ^a   Orlando, Paolo ^a   Panatto, Donatella ^a   Perdelli, Fernanda ^a   Cristina, Maria Luisa ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Carbapenem resistance; Infection control; Klebsiella pneumoniae

Indexed keywords

CARBAPENEM; CARBAPENEMASE;

BLOODSTREAM INFECTION; DISEASE SURVEILLANCE; HAND WASHING; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MENINGITIS; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; REVIEW; SURGICAL INFECTION; URINARY TRACT; WOUND INFECTION;

EID: 84891557171     PISSN: 0954139X     EISSN: 14735601     Source Type: Journal    
DOI: 10.1097/MRM.0b013e328365c51e     Document Type: Review

References (49)

1. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol Biol (Paris) 2012. doi: 10.1016/j.patbio.2012.10.004 [Epub ahead of print]
2. Sanchez GV, Master RN, Clark RB, Fyyaz M, Duvvuri P, Ekta G, et al. Klebsiella pneumoniae antimicrobial drug resistance, United States, 1998-2010. Emerg Infect Dis 2013; 19:133-136.
3. Bleumin D, Cohen MJ, Moranne O, Esnault VL, Benenson S, Paltiel O, et al. Carbapenem-resistant Klebsiella pneumoniae is associated with poor outcome in hemodialysis patients. J Infect 2012; 65:318-325.
4. Samra Z, Ofir O, Lishtzinsky Y, Madar-Shapiro L, Bishara J. Outbreak of carbapenem-resistant Klebsiella pneumoniae producing KPC-3 in a tertiary medical centre in Israel. Int J Antimicrob Agents 2007; 30:525-529.
5. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010; 16:102-111.
6. Mouloudi E, Protonotariou E, Zagorianou A, Iosifidis E, Karapanagiotou A, Giasnetsova T, et al. Bloodstream infections caused by metallo-b-lactamase/ Klebsiella pneumoniae carbapenemase-producing Kl. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes. Infect Control Hosp Epidemiol 2010; 31:1250-1256.
7. Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, et al. Carbapenem-nonsusceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. Euro Surveill 2010; 15. pii: 19711.
8. Beirão EM, Furtado JJ, Girardello R, Ferreira Filho H, Gales AC. Clinical and microbiological characterization of KPC-producing Klebsiella pneumoniae infections in Brazil. Braz J Infect Dis 2011; 15:69-73.
9. Buré A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis 1988; 7:780-782.
10. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001; 45:1151-1161.
11. Schwaber MJ, Lev B, Israeli A, Solter E, Smollan G, Rubinovitch B, et al. Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis 2011; 52:848-855.
12. European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm: ECDC; 2011.
13. Leavitt A, Chmelnitsky I, Carmeli Y, Navon-Venezia S. Complete nucleotide sequence of KPC-3-encoding plasmid pKpQIL in the epidemic Klebsiella pneumoniae sequence type 258. Antimicrob Agents Chemother 2010; 54:4493-4496.
14. Kaiser RM, Castanheira M, Jones RN, Tenover F, Lynfield R. Trends in Klebsiella pneumoniae carbapenemase-positive Kl. pneumoniae in US hospitals: report from the 2007-2009 SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 2013; 76:356-360.
15. Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis 2006; 12:1209-1213.
16. Giani T, Tascini C, Arena F, Ciullo I, Conte V, Leonildi A, et al. Rapid detection of intestinal carriage of Klebsiella pneumoniae producing KPC carbapenemase during an outbreak. J Hosp Infect 2012; 81:119-122.
17. Virgincar N, Iyer S, Stacey A, Maharjan S, Pike R, Perry C, et al. Klebsiella pneumoniae producing KPC carbapenemase in a district general hospital in the UK. J Hosp Infect 2011; 78:293-296.
18. Cuzon G, Naas T, Truong H, Villegas MV, Wisell KT, Carmeli Y, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 2010; 16:1349-1356.
19. Liu SW, Chang HJ, Chia JH, Kuo AJ, Wu TL, Lee MH. Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteraemia at a university hospital in Northern Taiwan: a matched case-control study. J Microbiol Immunol Infect 2012; 45:113-119.
20. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53:3365-3370.
21. Naparstek L, Carmeli Y, Chmelnitsky I, Banin E, Navon-Venezia S. Reduced susceptibility to chlorhexidine among extremely drug-resistant strains of Klebsiella pneumoniae. J Hosp Infect 2012; 81:15-19.
22. Fontana C, Favaro M, Sarmati L, Natoli S, Altieri A, Bossa MC, et al. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010; 3:40.
23. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenem-hydrolyzing b-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother 2005; 49:4423-4424.
24. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenemresistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother 2007; 51:3026-3029.
25. Pournaras S, Protonotariou E, Voulgari E, Kristo I, Dimitroulia E, Vitti D. Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece. J Antimicrob Chemother 2009; 64:348-352.
26. Wendt C, Schütt S, Dalpke AH, Konrad M, Mieth M, Trierweiler-Hauke B, et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing Kl. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29:563-570.
27. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791-1798.
28. Green DA, Srinivas N, Watz N, Tenover FC, Amieva M, Banaei N. A pediatric case of New Delhi metallo-betalactamase (NDM-1)-producing Enterobacteriaceae in the United States. Pediatr Infect Dis J 2013. [Epub ahead of print]
29. Bassetti M, Ginocchio F, Mikulska M. New treatment options against gram-negative organisms. Crit Care 2011; 15:215.
30. Sánchez-Romero I, Asensio A, Oteo J, Muñoz-Algarra M, Isidoro B, Vindel A, et al. Nosocomial outbreak of VIM-1- producing Klebsiella pneumoniae isolates of multilocus sequence type 15: molecular basis, clinical risk factors, and outcome. Antimicrob Agents Chemother 2012; 56:420-427.
31. Cagnacci S, Gualco L, Roveta S, Mannelli S, Borgianni L, Docquier JD, et al. Bloodstream infections caused by multidrug-resistant Klebsiella pneumoniae producing the carbapenem-hydrolysing VIM-1 metallo-beta-lactamase: first Italian outbreak. J Antimicrob Chemother 2008; 61:296-300.
32. Pasteran F, Albornoz E, Faccone D, Gomez S, Valenzuela C, Morales M, et al. Emergence of NDM-1-producing Klebsiella pneumoniae in Guatemala. J Antimicrob Chemother 2012; 67:1795-1797.
33. Kumarasamy KK, Toleman MA, Walsh TR, Bagaria J, Butt F, Balakrishnan R, et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 2010; 10:597-602.
34. Koh TH, Babini GS, Woodford N, Sng LH, Hall LM, Livermore DM. Carbapenem-hydrolysing IMP-1 beta-lactamase in Klebsiella pneumoniae from Singapore. Lancet 1999; 353: 2162.
35. Daoud Z, Hobeika E, Choucair A, Rohban R. Isolation of the first metallo-beta-lactamase producing Klebsiella pneumoniae in Lebanon. Rev Esp Quimioter 2008; 21:123-126.
36. Fukigai S, Alba J, Kimura S, Iida T, Nishikura N, Ishii Y, et al. Nosocomial outbreak of genetically related IMP-1 beta-lactamase-producing Klebsiella pneumoniae in a general hospital in Japan. Int J Antimicrob Agents 2007; 29:306-310.
37. Daikos GL, Karabinis A, Paramythiotou E, Syriopoulou VP, Kosmidis C, Avlami A, et al. VIM-1-producing Klebsiella pneumoniae bloodstream infections: analysis of 28 cases. Int J Antimicrob Agents 2007; 29:471-473.
38. Schwaber MJ, Carmeli Y. Carbapenem-resistant Enterobacteriaceae: a potential threat. J Am Med Assoc 2008; 300:2911-2913.
39. Perdelli F, Dallera M, Cristina ML, Sartini M, Ottria G, Spagnolo AM, et al. A new microbiological problem in intensive care units: environmental contamination by MRSA with reduced susceptibility to glycopeptides. Int J Hyg Environ Health 2008; 211:213-218.
40. Cristina ML, Spagnolo AM, Sartini M, Panatto D, Perdelli F. Clostridiumdifficile infections: an emerging problem in healthcare facilities. Rev Med Microbiol 2012; 23:67-75.
41. Lledo W, Hernandez M, Lopez E, Molinari OL, Soto RQ, Hernandez E, et al. Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWRMorb Mortal Wkly Rep 2009; 58:256-260.
42. Gregory CJ, Llata E, Stine N, Gould C, Santiago LM, Vazquez GJ, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol 2010; 31:476-484.
43. Ciobotaro P, Oved M, Nadir E, Bardenstein R, Zimhony O. An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice. Am J Infect Control 2011; 39:671-677.
44. Munoz-Price LS, Hayden MK, Lolans K, Won S, Calvert K, Lin M, et al. Successful control of an outbreak of Klebsiella pneumoniae carbapenemase- producing Kl. pneumoniae at a longterm acute care hospital. Infect Control Hosp Epidemiol 2010; 31:341-347.
45. Johnson PD, Martin R, Burrell LJ, Grabsch EA, Kirsa SW, O'Keeffe J, et al. Efficacy of an alcohol/chlorhexidine hand hygiene program in a hospital with high rates of nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection. Med J Aust 2005; 183:509-514.
46. Cristina ML, Spagnolo AM, Ottria G, Sartini M, Orlando P, Perdelli F, et al. Spread of multidrug carbapenem-resistant Acinetobacter baumannii in different wards of an Italian hospital. Am J Infect Control 2011; 39:790-794.
47. Cristina ML, Spagnolo AM, Cenderello N, Fabbri P, Sartini M, Ottria G, et al. Multidrug-resistant Acinetobacter baumannii outbreak: an investigation of the possible routes of transmission. Public Health 2013; 127:386-391.
48. Schechner V, Kotlovsky T, Kazma M, Mishali H, Schwartz D, Navon-Venezia S, et al. Predictors of rectal carriage of carbapenem-resistant Enterobacteriaceae (CRE) among patients with known CRE carriage at their next hospital encounter. Infect Control Hosp Epidemiol 2011; 32:497-503.
49. Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012; 27:128-142.